Skip to main content
SpringerLink
Log in

Positive recommendations from NICE

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE draft guidance recommends a treatment for prostate cancer. Media Release : 14 Apr 2014. Available from: URL: http://www.nice.org.uk.

  2. Ferring Pharmaceuticals, et al. UK NICE guidance recommends FIRMAGON(Rm) (degarelix) for the treatment of advanced hormone-dependent prostate cancer only in people with spinal metastases who present with signs or symptoms of impending spinal cord compression (ISCC). Media Release : 15 Apr 2014. Available from: URL: http://www.ferring.com.

  3. NICE. More options proposed for tackling anaemia in cancer patients. Media Release : 15 Apr 2014. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE publishes draft guidance on tests for bleeding problems during and after cardiac surgery. Media Release : 8 Apr 2014. Available from: URL: http://www.nice.org.uk.

  5. NICE. NICE opens consultation on `spray-on skin' device for healing burn wounds. Media Release : 16 Apr 2014. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Positive recommendations from NICE. PharmacoEcon Outcomes News 701, 9 (2014). https://doi.org/10.1007/s40274-014-1209-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1209-0

Search

Navigation